Results 11 to 20 of about 2,127,267 (265)

Neuromuscular blocking agents and reversal agents

open access: yes, 2005
The neuromuscular blocking agents in routine clinical use may be classed as depolarizing or nondepolarizing. Suxamethonium is the only example of the depolarizing group and is an agonist at the neuromuscular receptor.
Pollard, Brian J.
core   +9 more sources

Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study [PDF]

open access: yesPerioperative Medicine
Background Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. Methods Our objective was to describe and assess patterns in the use of neuromuscular blocking agents (NMBAs), neuromuscular transmission (
Piet Krijtenburg   +5 more
doaj   +2 more sources

Neuromuscular Blocking Agents

open access: yes
Neuromuscular Blocking Agents (NMBAs) are essential in anesthesia for muscle relaxation during surgical procedures. They are classified into non-depolarizing and depolarizing agents, with depolarizing agents activating acetylcholine receptors and non-depolarizing agents blocking them.
Adeyinka A, Layer DA.
openaire   +3 more sources

Use of Dexmedetomidine as an Adjuvant to Propofol along with Neurophysiological Monitoring of the Seventh Cranial Nerve during Cerebello- Pontine Tumour Excision Surgery [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Cerebello‑Pontine Angle (CPA) surgeries are very challenging for neurosurgeons as it lies very close to brain stem so various cranial nerves are at risk of damage. Generally, such surgeries require neuromuscular monitoring of various cranial nerves. For
POOJA ARPAN SHAH   +2 more
doaj   +1 more source

Template-Directed Synthesis of Bivalent, Broad-Spectrum Hosts for Neuromuscular Blocking Agents [PDF]

open access: yes, 2021
We report on the synthesis of bivalent water soluble calix[4]arene and calix[5]arene hosts, Super-sCx4 and Super-sCx5 as new broad-spectrum supramolecular binders of neuromuscular blocking agents (NMBAs).
Allison J., Selinger   +2 more
core   +1 more source

Association between neuromuscular blocking agent use and outcomes among out-of-hospital cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation and target temperature management: A secondary analysis of the SAVE-J II study

open access: yesResuscitation Plus, 2023
Background: Neuromuscular blocking agents are used to control shivering in cardiac arrest patients treated with target temperature management. However, their effect on outcomes in patients treated with extracorporeal cardiopulmonary resuscitation is ...
Masatoshi Uchida   +7 more
doaj   +1 more source

Pharmacodynamic interactions between muscle relaxants and other medications in practice of anesthesia [PDF]

open access: yesFarmacja Polska, 2023
Knowledge of drug interactions is an essential element of medical practice. Along with the increasing occurrence of multimorbidity and the associated multi-drug use, the number of possible combinations of preparations is constantly rising.
Paweł Radkowski, Rafał Marek Okoński
doaj   +1 more source

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents [PDF]

open access: yesJA Clinical Reports, 2019
Michiko Higashi   +2 more
doaj   +2 more sources

Resistance to non-depolarizing neuromuscular blocking agents [PDF]

open access: yes, 2020
The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents (NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune diseases which are thyroid disease ...
Dong-Min Hyun   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy